Imstem biotechnology inc
Witryna10 cze 2013 · Contact Information Website www.imstem.com Ownership Status Privately Held (backing) Financing Status Formerly VC-backed Primary Industry Drug Discovery Other Industries Biotechnology Primary Office 400 Farmington Avenue R1808 Call Box 111 Farmington, CT 06032 United States +1 (860) 000-0000 Want … Witryna30 paź 2024 · 2ImStem Biotechnology, Inc., 400 Farmington Avenue R1808, Farmington, CT 06030, USA. 3ZhuHai Hengqin ImStem Biotechnology Co., Ltd, …
Imstem biotechnology inc
Did you know?
WitrynaImStem Biotechnology, Inc The University of Texas Health Science Center at Houston / MD Anderson Cancer Center Company Website … http://en.imstem.com.cn/
http://en.imstem.com.cn/ WitrynaImstem Biotechnology, Inc's headquarters is located at 400 Farmington Ave R1706 Farmington, CT, 06030-0001 United States. What is Imstem Biotechnology, Inc's …
Witryna29 mar 2024 · ImStem Biotechnology, Inc. (“ImStem”), a biopharmaceutical company developing human embryonic stem cell (ESC)-derived mesenchymal stem cells, dosed the first U.S. multiple sclerosis (MS) patient with ImStem’s lead investigational drug candidate IMS001 at the Shepherd Center in Atlanta, GA. WitrynaImStem Biotechnology, Inc Jun 2024 - Present4 years 10 months San Francisco Bay Area Advancing the science and pipeline of human embryonic stem cell derived …
WitrynaImstem Biotechnology, Inc. is a biotechnology company focusing on developing cell therapeutic product derived from human pluripotent stem cells (hESC or iPSC) for …
Witryna20 mar 2024 · FARMINGTON, Conn., March 20, 2024 /PRNewswire/ -- ImStem Biotechnology, Inc. (Farmington CT), a biopharmaceutical company pioneering the development of human embryonic stem cell (ESC) derived mesenchymal stem cells (hES-MSC), through a proprietary method using a trophoblast intermediate stage … phillip smith and dunn braunton bungalowsWitrynaImStem was incorporated in 2012. As an innovative biopharmaceutical company, we aspire to improve patients' treatment outcomes and quality of life, targeting areas in … phillip smith architect cape girardeauWitrynaImStem Biotechnology, Inc. As an innovative biopharmaceutical company incorporated in 2012, we are committed to translating our research findings in stem cell medicine … phillip smith loan brokerWitrynaImStem Biotechnology, Inc. [pronounced as “I am stem (cells)”] is a biotechnology company focusing on developing a cell therapeutic product derived from human pluripotent stem cells (hESC or iPSC) for tissue repair, treatment of neural, heart, vascular, blood system diseases and autoimmune diseases. phillips mill innWitrynaImStem Biotechnology, Inc. is aspiring to revolutionize how serious diseases with significant unmet needs are treated with a new generation of regenerative and cellular therapies. Pioneering research led to the proprietary state-of-the-art pluripotent stem cell tec hnology, enabling off-the-shelf, allogeneic stem cell-derived products to be ... phillip smith dmd mahopacWitrynaFind company research, competitor information, contact details & financial data for Imstem Biotechnology, Inc. of Newport Beach, CA. Get the latest business insights from Dun & Bradstreet. phillip smith conwell architectsWitrynaAbout ImStem Biotechnology. Developer of commercial cell therapeutics to treat autoimmune diseases. The company's using human pluripotent cells to developing therapeutic products for tissue repair, and the treatment of neural, heart, vascular, blood system, and autoimmune diseases. phillip smith conwell